Metabolic syndrome is a group of health problems that include too much fat around the waist, elevated blood pressure, high triglycerides, elevated blood sugar, and low HDL cholesterol.
Together, this group of health problems increases your risk of heart attack, stroke, and diabetes.
Metabolic syndrome is caused by an unhealthy lifestyle that includes eating too many calories, being inactive, and gaining weight, particularly around your waist. This lifestyle can lead to insulin resistance, a condition in which the body is unable to respond normally to insulin. If you have insulin resistance, your body cannot use insulin properly, and your blood sugar will begin to rise. Over time, this can lead to type 2 diabetes.
If you have metabolic syndrome, you have several disorders of the metabolism at the same time, including obesity (usually around your waist), high blood pressure, low HDL cholesterol, and resistance to insulin.
This syndrome raises your risk for coronary artery disease (CAD), even beyond that caused by high LDL cholesterol alone.1
The things that make you more likely to develop metabolic syndrome include:2, 1
Your doctor can diagnose metabolic syndrome with a physical examination, your medical history, and some simple blood tests.
You may be diagnosed with metabolic syndrome if you have three or more of the risk factors listed in the table below. Note: These criteria were developed by the National Heart, Lung, and Blood Institute. Other organizations may have different criteria for diagnosis.
Central obesity or abdominal obesity (waist measurement) | Defining level |
|---|---|
People of European descent | Men: 94 cm or more; women: 80 cm or more |
South Asians | Men: 90 cm or more; women: 80 cm or more |
Chinese | Men: 90 cm or more; women: 80 cm or more |
Japanese | Men: 90 cm or more; women: 80 cm or more |
People of South and Central American descent | Men: 90 cm or more; women: 80 cm or more |
First Nations | Men: 90 cm or more; women: 80 cm or more |
People of African descent | Men: 94 cm or more; women: 80 cm or more |
People of Eastern Mediterranean and Middle Eastern descent | Men: 94 cm or more; women: 80 cm or more |
Plus two of the following | |
Triglycerides | Higher than 1.7 mmol/L |
High-density lipoprotein (HDL) cholesterol | Men: Less than 1.03 mmol/L Women: Less than 1.3 mmol/L |
Blood pressure | Higher than 130/85 mm Hg or taking medicine for high blood pressure |
Fasting blood sugar | Higher than 5.6 mmol/L |
The main goal of treatment is to reduce your risk of coronary artery disease (CAD) and diabetes. The first approaches in treating metabolic syndrome are:
| American Heart Association (AHA) | |
| 7272 Greenville Avenue | |
| Dallas, TX 75231 | |
| Phone: | 1-800-AHA-USA1 (1-800-242-8721) |
| Web Address: | www.heart.org |
Visit the American Heart Association (AHA) website for information on physical activity, diet, and various heart-related conditions. You can search for information on heart disease and stroke, share information with friends and family, and use tools to help you make heart-healthy goals and plans. Contact the AHA to find your nearest local or state AHA group. The AHA provides brochures and information about support groups and community programs, including Mended Hearts, a nationwide organization whose members visit people with heart problems and provide information and support. | |
| Canadian Diabetes Association | |
| 1400-522 University Avenue | |
| Toronto, ON M5G 2R5 | |
| Phone: | (416) 363-3373 1-800-BANTING (1-800-226-8464) |
| Email: | info@diabetes.ca |
| Web Address: | www.diabetes.ca |
The Canadian Diabetes Association (CDA) is devoted to meeting the needs of people with diabetes in Canada. This organization provides general information about diabetes and its care. It organizes summer camps for young people with diabetes and conducts educational seminars to help people manage their diabetes. The CDA also sells a range of products, including cookbooks, in its stores. | |
| Heart and Stroke Foundation of Canada | |
| 222 Queen Street | |
| Suite 1402 | |
| Ottawa, ON K1P 5V9 | |
| Phone: | (613) 569-4361 |
| Fax: | (613) 569-3278 |
| Web Address: | www.heartandstroke.ca |
The Heart and Stroke Foundation of Canada works to improve the health of Canadians by preventing and reducing disability and death from heart disease and stroke through research, health promotion, and advocacy. | |
| U.S. National Heart, Lung, and Blood Institute (NHLBI) | |
| P.O. Box 30105 | |
| Bethesda, MD 20824-0105 | |
| Phone: | (301) 592-8573 |
| Fax: | (240) 629-3246 |
| TDD: | (240) 629-3255 |
| Email: | nhlbiinfo@nhlbi.nih.gov |
| Web Address: | www.nhlbi.nih.gov |
The U.S. National Heart, Lung, and Blood Institute (NHLBI) information center offers information and publications about preventing and treating:
| |
Citations
- Grundy SM, et al. (2005). Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 112(17): 2735–2752.
- Genest J, et al. (2009). Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult—2009 recommendations. Canadian Journal of Cardiology, 25(10): 567–579.
Other Works Consulted
- Alberti K, et al. (2009). Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force of Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 120(16): 1640–1645.
- Brownlee M, et al. (2011). Complications of diabetes mellitus. In S Melmed et al., eds., Williams Textbook of Endocrinology, 12th ed., pp. 1462–1551. Philadelphia: Saunders.
- Brunzell JD (2010). Diagnosis and treatment of dyslipidemia. In EG Nabel, ed., ACP Medicine, section 9, chap. 6. Hamilton, ON: BC Decker.
- Eckel RH (2012). The metabolic sydrome. In DL Longo et al., eds., Harrison's Principals of Internal Medicine, 18th ed., vol. 2, pp. 1992–1997. New York: McGraw-Hill.
- Hawkins M, Rossetti L (2005). Insulin resistance and its role in the pathogenesis of type 2 diabetes. In Joslin's Diabetes Mellitus, 14th ed., pp. 425–448. Philadelphia: Lippincott Williams and Wilkins.
- Masharani U, German MS (2011). Pancreatic hormones and diabetes mellitus. In DG Gardner, D Shoback, eds., Greenspan's Basic and Clinical Endocrinology, 9th ed., pp. 573–655. New York: McGraw-Hill.
| By | Healthwise Staff |
|---|---|
| Primary Medical Reviewer | E. Gregory Thompson, MD - Internal Medicine |
| Primary Medical Reviewer | Brian D. O'Brien, MD - Internal Medicine |
| Specialist Medical Reviewer | Jennifer Hone, MD - Endocrinology, Diabetes and Metabolism |
| Last Revised | July 13, 2012 |
Next Section:
Other Places To Get HelpPrevious Section:
Topic OverviewNext Section:
Related InformationPrevious Section:
Other Places To Get HelpNext Section:
ReferencesPrevious Section:
Related InformationNext Section:
CreditsPrevious Section:
ReferencesLast Revised: July 13, 2012
This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
To learn more visit Healthwise.org
© 1995-2013 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.